140 related articles for article (PubMed ID: 11069329)
1. The safety and efficacy of cisatracurium 0.15 mg.kg(-1) during nitrous oxide-opioid anaesthesia in infants and children.
Taivainen T; Meakin GH; Meretoja OA; Wirtavuori K; Perkins RJ; Murphy AK; Fisher GR; Waiter MR
Anaesthesia; 2000 Nov; 55(11):1047-51. PubMed ID: 11069329
[TBL] [Abstract][Full Text] [Related]
2. Tracheal intubating conditions and pharmacodynamics following cisatracurium in infants and children undergoing halothane and thiopental-fentanyl anesthesia.
Meakin GH; Meretoja OA; Perkins RJ; Waite I; Taivainen T; Wirtavuori K; Murphy AK; Raiha L
Paediatr Anaesth; 2007 Feb; 17(2):113-20. PubMed ID: 17238881
[TBL] [Abstract][Full Text] [Related]
3. Cisatracurium during halothane and balanced anaesthesia in children.
Meretoja OA; Taivainen T; Wirtavuori K
Paediatr Anaesth; 1996; 6(5):373-8. PubMed ID: 8880817
[TBL] [Abstract][Full Text] [Related]
4. Effects of cisatracurium in children during halothane-nitrous oxide anesthesia.
Brandom BW; Woelfel SK; Ference A; Dayal B; Cook DR; Kerls S
J Clin Anesth; 1998 May; 10(3):195-9. PubMed ID: 9603588
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic dose-response and safety study of cisatracurium (51W89) in adult surgical patients during N2O-O2-opioid anesthesia.
Lepage JY; Malinovsky JM; Malinge M; Lechevalier T; Dupuch C; Cozian A; Pinaud M; Souron R
Anesth Analg; 1996 Oct; 83(4):823-9. PubMed ID: 8831329
[TBL] [Abstract][Full Text] [Related]
6. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.
Stevens JB; Walker SC; Fontenot JP
Anesth Analg; 1997 Dec; 85(6):1278-83. PubMed ID: 9390594
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the neuromuscular blocking effects and reversibility of cisatracurium and atracurium.
Carroll MT; Mirakhur RK; Lowry D; Glover P; Kerr CJ
Anaesthesia; 1998 Aug; 53(8):744-8. PubMed ID: 9797517
[TBL] [Abstract][Full Text] [Related]
8. [Neuromuscular blockade with cisatracurium in infants andchildren. Its course under sevoflurane anesthesia].
Soltész S; Silomon M; Mencke T; Schlaich N; Fuchs-Buder T
Anaesthesist; 2002 May; 51(5):374-7. PubMed ID: 12125308
[TBL] [Abstract][Full Text] [Related]
9. The pharmacodynamics of mivacurium preceded by atracurium or cisatracurium in children.
Jalkanen L; Rautoma P; Taivainen T; Meretoja OA
Anesth Analg; 1998 Jan; 86(1):62-5. PubMed ID: 9428852
[TBL] [Abstract][Full Text] [Related]
10. Assessment of neuromuscular and haemodynamic effects of cisatracurium and vecuronium under sevoflurane-remifentanil anaesthesia in elderly patients.
Keleş GT; Yentür A; Cavuş Z; Sakarya M
Eur J Anaesthesiol; 2004 Nov; 21(11):877-81. PubMed ID: 15717704
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacology of cisatracurium during nitrous oxide-propofol anesthesia in children.
ShangGuan W; Lian Q; Li J; Gao F
J Clin Anesth; 2008 Sep; 20(6):411-4. PubMed ID: 18929279
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the neuromuscular blocking effect of cisatracurium and atracurium on the larynx and the adductor pollicis.
Kirov K; Motamed C; Decailliot F; Behforouz N; Duvaldestin P
Acta Anaesthesiol Scand; 2004 May; 48(5):577-81. PubMed ID: 15101851
[TBL] [Abstract][Full Text] [Related]
13. [Cisatracurium in patients with compromised kidney function. Pharmacodynamic and intubation conditions under isoflurane-nitrous oxide anesthesia].
Soukup J; Czeslick E; Bunk S; Clausen T; Menzel M; Radke J
Anaesthesist; 1998 Aug; 47(8):669-76. PubMed ID: 9770090
[TBL] [Abstract][Full Text] [Related]
14. [Priming technique with cisatracurium Onset time at the laryngeal muscles].
Schmidt J; Albrecht S; Petterich N; Fechner J; Klein P; Irouschek A
Anaesthesist; 2007 Oct; 56(10):992-1000. PubMed ID: 17598079
[TBL] [Abstract][Full Text] [Related]
15. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination.
Kim KS; Chun YS; Chon SU; Suh JK
Anaesthesia; 1998 Sep; 53(9):872-8. PubMed ID: 9849281
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of the neuromuscular blocking effects of cisatracurium during desflurane, sevoflurane, isoflurane or total i.v. anaesthesia.
Wulf H; Kahl M; Ledowski T
Br J Anaesth; 1998 Mar; 80(3):308-12. PubMed ID: 9623429
[TBL] [Abstract][Full Text] [Related]
17. [Cisatricurium in the orbicularis oculi muscle. Comparisn of the neuromuscular action of cisatracurium and atracurium in the orbicularis oculi muscle and the adductor pollicis muscle].
de Rossi L; Fritz H; Kröber L; Klein U
Anaesthesist; 1999 Sep; 48(9):602-6. PubMed ID: 10525592
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of cisatracurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia.
Lien CA; Schmith VD; Belmont MR; Abalos A; Kisor DF; Savarese JJ
Anesthesiology; 1996 Feb; 84(2):300-8. PubMed ID: 8602660
[TBL] [Abstract][Full Text] [Related]
19. Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other nondepolarising relaxants.
Carroll MT; Mirakhur RK; Lowry DW; McCourt KC; Kerr C
Anaesthesia; 1998 Dec; 53(12):1169-73. PubMed ID: 10193219
[TBL] [Abstract][Full Text] [Related]
20. Comparison of neuromuscular effects, efficacy and safety of rocuronium and atracurium in ambulatory anaesthesia.
Whalley DG; Maurer WG; Knapik AL; Estafanous FG
Can J Anaesth; 1998 Oct; 45(10):954-9. PubMed ID: 9836032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
